Poster: Depletion of CCR8 Tumor Treg cells with SRF114 or Anti-CCR8 Therapy Promotes Robust Antitumor Activity and Reshapes the Tumor Microenvironment Toward a More Pro-inflammatory Milieu
AACR Annual Meeting, April 2023
Poster: SRF114, an Afucosylated Anti-CCR8 Antibody, Depletes Intratumoral Treg Cells and Inhibits Tumor Growth
Society for Immunotherapy of Cancer Annual Meeting, November 2022
Publication: Fc-optimized anti-CCR8 antibody depletes regulatory T cells in human tumor models
American Association for Cancer Research, March 2021
Poster: SRF114 is a Fully Human, CCR8-Selective IgG1 Antibody that Induces Destruction of Tumor Tregs Through ADCC
Society for Immunotherapy of Cancer Annual Meeting, November 2020